LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1209 | 2281 | 3823 | 0.5967 | 0.4654 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1209 | 2112 | 4093 | 0.5159 | 0.3728 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1209 | 2122 | 4121 | 0.5149 | 0.3741 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1209 | 1971 | 3823 | 0.5156 | 0.3419 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1209 | 2094 | 4093 | 0.5115 | 0.3662 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1209 | 2074 | 4121 | 0.5033 | 0.3565 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1209 | 1993 | 3823 | 0.5213 | 0.3509 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1209 | 2076 | 4093 | 0.5071 | 0.3595 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1209 | 1928 | 4121 | 0.4678 | 0.3016 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 1209 | 2055 | 3823 | 0.5375 | 0.3761 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 1209 | 2029 | 4093 | 0.4956 | 0.3419 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 1209 | 1909 | 4121 | 0.4632 | 0.2944 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 1209 | 3013 | 3980 | 0.7570 | 0.7009 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 1209 | 3315 | 4252 | 0.7795 | 0.7434 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 1209 | 3485 | 4376 | 0.7964 | 0.7690 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1209 | 2696 | 3980 | 0.6774 | 0.5943 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 1209 | 3195 | 4252 | 0.7513 | 0.7083 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1209 | 3035 | 4376 | 0.6935 | 0.6420 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 1209 | 2151 | 3980 | 0.5404 | 0.3980 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 2 | O22 | 72 | hr | 1209 | 2406 | 4252 | 0.5658 | 0.4610 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 1209 | 2450 | 4376 | 0.5599 | 0.4630 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 1209 | 1941 | 3980 | 0.4877 | 0.3169 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 2 | O21 | 72 | hr | 1209 | 2246 | 4252 | 0.5281 | 0.4066 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 3 | O21 | 72 | hr | 1209 | 1974 | 4376 | 0.4511 | 0.3022 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 1209 | 1862 | 3980 | 0.4678 | 0.2854 |